Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $39.6100 (-0.35%) ($39.5100 - $39.6100) on Wed. Sep. 20, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.27% (three month average) | RSI | 37 | Latest Price | $39.6100(-0.35%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.7% a day on average for past five trading days. | Weekly Trend | HALO declines -2.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) UNG(87%) HYG(61%) JNK(61%) BNDX(49%) BND(33%) | Factors Impacting HALO price | HALO will decline at least -1.135% in a week (0% probabilities). IPO(-62%) IWM(-93%) IWC(-58%) SIL(-53%) EWG(-51%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.135% (StdDev 2.27%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $40.7 | 5 Day Moving Average | $39.61(0%) | 10 Day Moving Average | $39.33(0.71%) | 20 Day Moving Average | $40.7(-2.68%) | To recent high | -10.1% | To recent low | 16.1% | Market Cap | $5.414b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |